Filter Results :

Your search for Infection returned 444 reports

Sort by


Infection Control Market by Disinfection (Endoscope Reprocessing, Disinfectant, Disinfector, Surgical Drapes, Gowns, Disinfectant Wipes, Face Mask), Sterilization (Moist Heat, Dry Heat, Ethylene Oxide, E-beam, Contract Services) - Global Forecast to 2020

18 Jun 2015  |  Published by:  MarketsandMarkets
Report Description Sterilization and disinfection are essential components of infection control procedures. New technologies like E-beam and gamma are poised to garner strong market shares in the future, due to their greater product compatibility and low prices. These technologies have been...

$ 4,650.00

Read More

Herpes Simplex Infections Global Clinical Trials Review, H1, 2015

27 May 2015  |  Published by:  GlobalData
Summary“Herpes Simplex Infections Global Clinical Trials Review, H1, 2015" provides an overview of Herpes Simplex Infections clinical trials scenario. This report provides top line data relating to the clinical trials on Herpes Simplex Infections. Report includes an overview of trial numbers and the...

$ 2,500.00

Read More

Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections - Pipeline Review, H1 2015’, provides an overview of the Methicillin-Susceptible Staphylococcus Aureus (MSSA) Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Me...

$ 2,000.00

Read More

Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Vancomycin Resistant Staphylococcus Aureus Infection (VRSA) - Pipeline Review, H1 2015’, provides an overview of the Vancomycin Resistant Staphylococcus Aureus Infection (VRSA)’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Vancomycin...

$ 2,000.00

Read More

Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015

20 May 2015  |  Published by:  Global Markets Direct
Summary‘Burkholderia Pseudomallei Infections - Pipeline Review, H1 2015’, provides an overview of the Burkholderia Pseudomallei Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Burkholderia Pseudomallei Infections, complete with comp...

$ 2,000.00

Read More

Healthcare-Acquired Infection: Devices, Pharmaceuticals, and Environmental Products

20 May 2015  |  Published by:  BCC Research
The global market for selected healthcare-acquired infection (HAI) treatments was valued at nearly $15.2 billion in 2014. This market is expected to increase from nearly $17.1 billion in 2015 to $23 billion by 2020, with a compound annual growth rate (CAGR) of 6.1% from 2015 to 2020. This rep...

$ 6,650.00

Read More

Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015

20 May 2015  |  Published by:  GlobalData
Summary“Shigella Infections (Shigellosis) Global Clinical Trials Review, H1, 2015" provides data on the Shigella Infections (Shigellosis) clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Shigella Infections (Shigellosis). It includes an ...

$ 2,500.00

Read More

Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2015

13 May 2015  |  Published by:  Global Markets Direct
Summary‘Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2015’, provides an overview of the Hospital Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline.This report provides comprehensive information on th...

$ 2,000.00

Read More

Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015

30 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Varicella Zoster (HHV-3) Infections - Pipeline Review, H1 2015’, provides an overview of the Varicella Zoster (HHV-3) Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Varicella Zoster (HHV-3) Infectio...

$ 2,000.00

Read More

West Nile Virus Infections - Pipeline Review, H1 2015

30 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘West Nile Virus Infections - Pipeline Review, H1 2015’, provides an overview of the West Nile Virus Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for West Nile Virus Infections, complete with comparati...

$ 2,000.00

Read More

Chlamydia Infections - Pipeline Review, H1 2015

30 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Chlamydia Infections - Pipeline Review, H1 2015’, provides an overview of the Chlamydia Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Chlamydia Infections, complete with comparative analysis at var...

$ 2,000.00

Read More

Rotavirus Infections - Pipeline Review, H1 2015

29 Apr 2015  |  Published by:  Global Markets Direct
Summary‘Rotavirus Infections - Pipeline Review, H1 2015’, provides an overview of the Rotavirus Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Rotavirus Infections, complete with comparative analysis at various stages, therapeutics...

$ 2,000.00

Read More

Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015

29 Apr 2015  |  Published by:  Global Markets Direct
Summary‘Resistant Pseudomonas Aeruginosa Infections - Pipeline Review, H1 2015’, provides an overview of the Resistant Pseudomonas Aeruginosa Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Resistant Pseudomonas Aeruginosa Infection...

$ 2,000.00

Read More

Neisseria Meningitidis Infections - Pipeline Review, H1 2015

22 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Neisseria Meningitidis Infections - Pipeline Review, H1 2015’, provides an overview of the Neisseria Meningitidis Infections’s therapeutic pipeline.This report provides comprehensive information on the therapeutic development for Neisseria Meningitidi...

$ 2,000.00

Read More

Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2015

15 Apr 2015  |  Published by:  Global Markets Direct
SummaryGlobal Markets Direct’s, ‘Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections - Pipeline Review, H1 2015’, provides an overview of the Community Acquired Methicillin-Resistant Staphylococcus Aureus (MRSA) Infections’s therapeutic pipeline.This report provides comp...

$ 2,000.00

Read More
Total 444 records.